HC

HCA Healthcare, Inc.

HCAHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$75.60B
+7.1% YoY
Net Income
$6.78B
+17.8% YoY
EBITDA
$15.60B
+12.3% YoY
Free Cash Flow
$3.74B

Scan Results

Daily timeframe
10 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 16CONFIRMED▼ RSI OverboughtRSI 74.7, above 70, stock may be overbought
Oct 15CONFIRMED▼ RSI OverboughtRSI 80.6, above 70, stock may be overbought
About HCA Healthcare, Inc.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company carries a $104.05B market cap, placing it firmly in the large-cap category. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities.

Where HCA stands vs its 150-day and 200-day moving averages

As of the October 16, 2026 close, HCA finished 10.47% above its 150-day moving average ($424.09) and 5.63% above its 200-day moving average ($443.53). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is HCA overbought or oversold?

At the October 16, 2026 close, HCA's RSI(14) was 74.7, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$104.05B
P/E (TTM)15.72
Fwd P/E14.66
EPS$29.83
Beta1.11
52W Change+0.3%
Dividend Yield0.67%
Analysis

The company holds $1.13B in cash, though total debt stands at $51.55B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $3.74B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on assets of 12.3% further supports the picture of efficient asset utilization. Revenue has grown from $60.23B (2022) to $75.60B (2025), reflecting a 26% increase over the period.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. No single metric tells the full story. Reviewing HCA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms